Skip to main content
SpringerLink
Log in

Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis

  • Clinical Trials Report
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Llewelyn M, Cohen J: New insights into the pathogenesis and therapy of sepsis and septic shock. In Current Clinical Topics in Infectious Diseases, volume 21. Edited by Remington JS, Schwartz MN. Malden, MA: Blackwell Science; 2001:148–171.

    Google Scholar 

  2. van Deuren M, Brandtzaeg P: Commentary. Parents’ and GPs’ key role in diagnosis of meningococcal septicemia Lancet 2000, 356:954–955.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Neal H. Steigbigel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steigbigel, N.H. Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis. Curr Infect Dis Rep 3, 405–406 (2007). https://doi.org/10.1007/s11908-007-1006-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-007-1006-z

Keywords

Search

Navigation